15 Stock Market News for "IMGN"

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunoGen, Inc. IMGN

NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of ImmunoGen, Inc. (“ImmunoGen” or the “Company”) (NASDAQ: IMGN).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The investigation concerns whether ImmunoGen and certain of its officers and/or directors have... »

Health Care Sector Update for 05/15/2019: ABBV,ACB,ACB.TO,ECOR,IMGN

Shutterstock photo Top Health Care Stocks JNJ +0.12% PFE +1.36% ABT +0.85% MRK +0.39% AMGN +1.38% Health care stocks still were rising, with the NYSE Health Care Index adding almost 0.6% in value late Wednesday while shares of health care companies in the S&P 500 were up slightly more than 0.4% as a group. The Nasdaq Biotechnology index was climbing nearly 0.8% just before the closing bell. Am... »

Health Care Sector Update for 05/15/2019: ECOR, ACB, IMGN

Shutterstock photo Top Health Care Stocks JNJ +0.21% PFE +1.24% ABT +0.63% MRK +0.37% AMGN +0.94% Health care stocks were rising, including a nearly 0.4% gain for the NYSE Health Care Index in recent trade. Shares of health care companies in the S&P 500 also were up more than 0.3% as a group while the Nasdaq Biotechnology index was climbing over 0.4%. Among health care stocks moving on news: (... »

Health Care Sector Update for 05/15/2019: IMGN, A, ACBI, JNJ, PFE, ABT, MRK, AMGN

Shutterstock photo Top Health Care Stocks: JNJ: Flat PFE: +0.34% ABT: Flat MRK: Flat AMGN: Flat Leading health care stocks were flat to higher pre-market Wednesday. Stocks moving on news include: (-) ImmunoGen ( IMGN ), which was slumping more than 30% after the US Food and Drug Administration (FDA) recommended that the company conduct a new phase-three trial for mirvetuximab soravtansine in patie... »

Pawar Law Group Reminds Investors of July 15 Deadline in Securities Class Action Lawsuit Against AAC Holdings, Inc. – AAC

NEW YORK, June 21, 2019 (GLOBE NEWSWIRE) — Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of AAC Holdings, Inc. (NYSE: AAC) from March 8, 2017 through April 15, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for AAC investors under the federal securities laws.To join the AAC class action, go to&n... »

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against KushCo Holdings, Inc.

LOS ANGELES, June 20, 2019 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 1, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of KushCo Holdings, Inc.  (“KushCo” or the “Company”) (OTC: KSHB) investors who purchased securities between July 13, 2017 and April 9, 2019, inclusive (the “C... »

Medic.life Premieres New Technology to Proactively Monitor Your Health While Carrying out Your Daily Routines

PROVO, Utah–(BUSINESS WIRE)–Medic.life (www.medic.life), a pioneer in the advancement of science to support wellness, has developed technology to monitor key health and wellness indicators during every bathroom stop. Since 1999, Medic has been perfecting new technology for an AI toilet that gathers wellness data and identifies trends, with no disruption to users’ daily routines. Medic’... »

The Week Ahead In Biotech: ASCO Presentations In The Spotlight

After two successive weeks of losses, biotech stocks slowly clawed back. Multiple conference presentations, independent clinical trial readouts and a few FDA decisions marked the key events in the biotech space. Among the notable biotech movers of the week: BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), which suffered a severe setback despite a positive readout from a late-stage trial of its ... »

Cie CEO Anderee Berengian Named Finalist for The EY Entrepreneur Of The Year® 2019 Award in the Orange County Region

IRVINE, Calif., May 20, 2019 (GLOBE NEWSWIRE) — Cie, the venture accelerator that re-imagines businesses at the intersection of commerce, technology and humanity, has announced that Cie Co-founder and CEO Anderee Berengian has been named a finalist for the Entrepreneur Of The Year® 2019 Award in the Orange County Region. Last year, Anderee won the 2018 OCBJ Excellence In ... »

The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics

Here’s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 15) Applied Therapeutics Inc (NASDAQ: APLT) (debuted on Tuesday) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) Avedro Inc (NASDAQ: AVDR) Axsome Therapeutics Inc (NASDAQ: AXSM) MeiraGTx Holdings PLC (NASDAQ: MGTX) Shockwave Medical Inc (NASDAQ: SWAV) Si... »

ImmunoGen Announces Mature Data from FORWARD II Expansion Cohort Evaluating Mirvetuximab Soravtansine in Combination with Avastin® in Ovarian Cancer

WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced mature data from the FORWARD II expansion cohort evaluating mirvetuximab soravtansine in combination with Avastin® (bevacizumab) in patients with folate receptor alpha (FRα)-positive platinum-resistant ovarian ca... »

44 Stocks Moving In Wednesday’s Mid-Day Session

Gainers Global Eagle Entertainment Inc (NASDAQ: ENT) shares jumped 42.5 percent to $1.1255 after the company reported better-than-expected Q1 sales results and reported Q1 EPS in-line with analyst estimates. PDS Biotechnology Corporation (NASDAQ: PDSB) shares jumped 37.8 percent to $8.46 after the company reported Q1 EPS increased 712.5 percent from last year.. Yogaworks Inc (NASDAQ: YOGA) shares ... »

ImmunoGen Provides Regulatory Update on Mirvetuximab Soravtansine Monotherapy in Ovarian Cancer

WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced the United States Food and Drug Administration (FDA) has recommended that the Company conduct a new Phase 3 randomized trial to evaluate the safety and efficacy of mirvetuximab soravtansine in patients with high ... »

30 Stocks Moving In Monday’s Mid-Day Session

Gainers Bridgeline Digital, Inc. (NASDAQ: BLIN) shares jumped 56 percent to $8.28. Aemetis Inc (NASDAQ: AMTX) climbed 51.2 percent to $1.27 after the company won a $23 million biodiesel supply contract with India state-owned oil companies. Aquantia Corp. (NYSE: AQ) shares gained 36.2 percent to $13.02 after the company announced it will be acquired by Marvell for $13.25 per share in cash, equaling... »

80 Biggest Movers From Friday

Gainers Regional Health Properties, Inc. (NYSE: RHE) shares jumped 40 percent to close at $3.50 on Friday. Zix Corporation (NASDAQ: ZIXI) shares rose 34.63 percent to close at $11.08 after the company reported better-than-expected Q1 EPS and sales results. The company also gave strong guidance. Yunji Inc. (NASDAQ: YJ) gained 28.64 percent to close at $14.15 after the company priced its 11 million ... »